1. Home
  2. NOTV vs WIMI Comparison

NOTV vs WIMI Comparison

Compare NOTV & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • WIMI
  • Stock Information
  • Founded
  • NOTV 1974
  • WIMI 2015
  • Country
  • NOTV United States
  • WIMI China
  • Employees
  • NOTV N/A
  • WIMI N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • WIMI Computer Software: Prepackaged Software
  • Sector
  • NOTV Health Care
  • WIMI Technology
  • Exchange
  • NOTV Nasdaq
  • WIMI Nasdaq
  • Market Cap
  • NOTV 46.7M
  • WIMI 51.6M
  • IPO Year
  • NOTV 1997
  • WIMI 2020
  • Fundamental
  • Price
  • NOTV $1.17
  • WIMI $3.22
  • Analyst Decision
  • NOTV Strong Buy
  • WIMI
  • Analyst Count
  • NOTV 1
  • WIMI 0
  • Target Price
  • NOTV $5.00
  • WIMI N/A
  • AVG Volume (30 Days)
  • NOTV 385.3K
  • WIMI 209.6K
  • Earning Date
  • NOTV 12-02-2025
  • WIMI 01-01-0001
  • Dividend Yield
  • NOTV N/A
  • WIMI N/A
  • EPS Growth
  • NOTV N/A
  • WIMI N/A
  • EPS
  • NOTV N/A
  • WIMI 1.43
  • Revenue
  • NOTV $505,299,000.00
  • WIMI $61,329,146.00
  • Revenue This Year
  • NOTV $5.64
  • WIMI N/A
  • Revenue Next Year
  • NOTV $5.16
  • WIMI N/A
  • P/E Ratio
  • NOTV N/A
  • WIMI $2.45
  • Revenue Growth
  • NOTV 0.85
  • WIMI N/A
  • 52 Week Low
  • NOTV $1.12
  • WIMI $2.24
  • 52 Week High
  • NOTV $6.48
  • WIMI $29.20
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 34.68
  • WIMI 31.60
  • Support Level
  • NOTV $1.12
  • WIMI $3.39
  • Resistance Level
  • NOTV $1.43
  • WIMI $4.16
  • Average True Range (ATR)
  • NOTV 0.09
  • WIMI 0.22
  • MACD
  • NOTV -0.01
  • WIMI -0.06
  • Stochastic Oscillator
  • NOTV 19.72
  • WIMI 5.45

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

Share on Social Networks: